Search

everythinglearnresearchcommunity

for

Search:↓

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Some common medications can harm male fertility, but many effects can be reversed.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

Men with benign prostatic hyperplasia are more likely to have metabolic syndrome than those without it.

5-alpha-reductase inhibitors may cause a low incidence of erectile dysfunction that decreases over time.

Finasteride irreversibly affects human steroid 5α-reductase 2, providing insight into its catalytic mechanism and disease-related mutations.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

Consider benefits and risks of new alopecia treatments for safety.

DA-9401 helps protect rat testis from finasteride damage.

Some treatments can stabilize Frontal Fibrosing Alopecia, but more research is needed to find effective treatments, and hair transplants often fail.

New treatments for skin and hair disorders in women of color address unique biological differences and include specific acne medications, sunscreens, skin lighteners, and hair care adjustments.

The review suggests there's no agreed treatment for Frontal Fibrosing Alopecia, but hydroxychloroquine and 5a-reductase inhibitors are most effective. New treatments like platelet-rich plasma and LED light could help if standard treatments fail.

Post-finasteride syndrome's existence is uncertain; more research needed.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Higher DHT levels are linked to fewer hypogonadism symptoms in men with normal testosterone levels.

5-alpha-reductase inhibitors help treat urinary symptoms from an enlarged prostate.

Using 5α-reductase inhibitors for hair loss can cause lasting sexual, physical, mental, and vascular health issues in men, even after stopping the medication.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.

Higher SRD5A2 expression predicts better response to finasteride in treating urinary symptoms.

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

Saw palmetto may cause erectile dysfunction and needs better safety monitoring.

The herbal mixture could potentially improve hair loss.

Dutasteride and finasteride cause kidney damage, with dutasteride being more harmful.

The research found that compound 6, a newly created steroid, is more effective at inhibiting 5α-reductase (an enzyme) than current treatments, suggesting it could be a better option for treating urinary tract symptoms in men.